In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
Microbot Medical Inc (NASDAQ: MBOT) closed the day trading at $2.34 down -5.65% from the previous closing price of $2.48. In other words, the price has decreased by -$5.65 from its previous closing price. On the day, 1.32 million shares were traded.
Ratios:
For a better understanding of MBOT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 16.19 and its Current Ratio is at 16.19. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on January 13, 2020, Reiterated its Buy rating but revised its target price to $26 from $12 previously.
On December 24, 2019, H.C. Wainwright reiterated its Buy rating and also lowered its target price recommendation from $10 to $12.
On January 31, 2018, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $1.75.Ladenburg Thalmann initiated its Buy rating on January 31, 2018, with a $1.75 target price.
Stock Price History:
Over the past 52 weeks, MBOT has reached a high of $3.38, while it has fallen to a 52-week low of $0.82. The 50-Day Moving Average of the stock is -2.99%, while the 200-Day Moving Average is calculated to be 48.99%.
Shares Statistics:
A total of 36.38M shares are outstanding, with a floating share count of 35.98M. Insiders hold about 1.09% of the company’s shares, while institutions hold 11.05% stake in the company.
